That may be a reason why Rosen thought they could get away with greenmailing CTIX, or if the conspiracy theories are true, being involved with the take-down. They were going back to the well again. PYMX failed, CTIX bought them, ergo (they erroneously thought) we can take them down like we did PYMX.
That may account for all the bashing on the recent SA article's comments, based on the supposed side effects of Brilacidin -- that writer was using the old PYMX data instead of the current data with much lower doses that CTIX is using.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links